Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Long-Term Bleeding Protection, Sustained FIX Activity, Reduction of FIX Consumption and Safety of Hemophilia B Gene Therapy: Results from the HOPE-B Trial 3 Years after Administration of a Single Dose of Etranacogene Dezaparvovec in Adult Patients with Severe or Moderately Severe Hemophilia B

Blood (2023) 142 (Supplement 1): 1055.

https://doi.org/10.1182/blood-2023-187624

Published: 2023

Journal Articles

Adult Patients with Hemophilia B and with a History of Chronic HCV/HBV Infection Receiving Liver-Directed Gene Therapy Demonstrated Long-Term Bleeding Protection and Sustained FIX Activity: Efficacy and Safety Results from the HOPE-B Trial 3 Years after Administration of a Single Dose of Etranacogene Dezaparvovec

Annette von Drygalski, Niamh O'Connell, Peter Verhamme, Karina Meijer, Paul van der Valk, Rashid Saeed Kazmi, Priyanka Raheja, Nicholas Galante, Sandra LeQuellec, Rachel Church, Samantha Lucas, Giancarlo Castaman, Paul Monahan

Blood (2023) 142 (Supplement 1): 2258.

https://doi.org/10.1182/blood-2023-188921

Published: 2023

Journal Articles

Effects of Andexanet Alfa on Thrombin Generation in Bleeding Associated with Factor Xa Inhibitors

Michiel Coppens, MD, Lizhen Xu, PhD, Roisin Bavalia, MD, Saskia Middeldorp, MD PhD, Peter Verhamme, MD PhD, John W. Eikelboom, MBBS, MSc, FRACP, FRCPA, Mark Crowther, MD, Genmin Lu, Patrick Yue, MD, Pamela B. Conley, PhD, Stuart J. Connolly, MD MSc, FRCPC

Blood (2019) 134 (Supplement_1): 711.

https://doi.org/10.1182/blood-2019-124596

Published: 2019

Journal Articles

Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study: A Perioperative Management Plan for Patients with Atrial Fibrillation Who Are Receiving a Direct Oral Anticoagulant

Blood (2018) 132 (Supplement 1): LBA-5.

https://doi.org/10.1182/blood-2018-120770

Published: 2018

Journal Articles

D-Dimer Levels and Risk of Recurrence Following Provoked Venous Thromboembolism: Findings from the Riete Registry

Martin Ellis, MD, Martin Mar, Monreal Manuel, MD, Orly Hamburger-Avnery, MD, Alessandra Bura-Riviere, Giovanni Barillari, Lucia Mazzolai, Isabelle Mahe, MD, Pablo Javier Marchena, Peter Verhamme, MD PhD

Blood (2018) 132 (Supplement 1): 3810.

https://doi.org/10.1182/blood-2018-99-111190

Published: 2018

Journal Articles

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Gary E. Raskob, PhD, Nick Van Es, MD, Peter Verhamme, MD PhD, Marc Carrier, MD, Marcello Di Nisio, MD, David A. Garcia, MD, Michael A. Grosso, MD, Ajay K. Kakkar, MBBS, Michael J. Kovacs, MD, Michele F. Mercuri, MD PhD FAHA, Guy Meyer, MD, Annelise Segers, MD, Minggao Shi, PhD, Tzu-Fei Wang, MD, Erik Yeo, MD FACP, FRCPC, George Zhang, PhD, Jeffrey I. Zwicker, MD, Jeffrey I. Weitz, MD, Harry R. Büller, MD PhD

Blood (2017) 130 (Supplement 1): LBA-6.

https://doi.org/10.1182/blood.V130.Suppl_1.LBA-6.LBA-6

Published: 2017

Journal Articles

Interm Report of the Highlow Study: A Randomized Controlled Trial Comparing Two Doses of Low Molecular Weight Heparin for the Prevention of Pregnancy-Associated Recurrent Venous Thromboembolism

Suzanne M Bleker, MD, Bistervels M Ingrid, MD, Andrea Buchmüller, Céline Chauleur, Fionnuala Ní Áinle, MD PhD, Jennifer Donnelly, Peter Verhamme, Anne Flem Jacobsen, Hervé Décousus, Saskia Middeldorp, MD PhD

Blood (2016) 128 (22): 1444.

https://doi.org/10.1182/blood.V128.22.1444.1444

Published: 2016

Journal Articles

Allele-specific DNA methylation reinforces PEAR1 enhancer activity

Benedetta Izzi, Mariaelena Pistoni, Katrien Cludts, Pinar Akkor, Diether Lambrechts, Catherine Verfaillie, Peter Verhamme, Kathleen Freson, Marc F. Hoylaerts

Blood (2016) 128 (7): 1003–1012.

https://doi.org/10.1182/blood-2015-11-682153

Published: 2016

Includes: Supplemental data

Journal Articles

Antithrombotic Treatment and Outcomes of Splanchnic Vein Thrombosis in an International Prospective Registry: Results of 2-Year Follow-up

Walter Ageno, MD, Nicoletta Riva, Sam Schulman, MD PhD, Jan Beyer-Westendorf, MD, Soo-Mee Bang, Marco Senzolo, Elvira Grandone, Giovanni Barillari, Matteo Di Minno, Rita Duce, Alessandra Malato, Rita Santoro, Daniela Poli, Peter Verhamme, MD PhD, Ida Martinelli, Pieter W. Kamphuisen, MD PhD, Francesco Dentali, MD

Blood (2014) 124 (21): 592.

https://doi.org/10.1182/blood.V124.21.592.592

Published: 2014

Journal Articles

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

Harry Roger Buller, MD PhD, Claudette Bethune, PhD, Sanjay Bhanot, MDPhD, David Gailani, MD, Brett P. Monia, PhD, Gary E. Raskob, PhD, Annelise Segers, Peter Verhamme, MD PhD, Jeffrey I. Weitz, MDFRCPC

Blood (2014) 124 (21): LBA-1.

https://doi.org/10.1182/blood.V124.21.LBA-1.LBA-1

Published: 2014

Journal Articles

Adhesion of Staphylococcus aureus to the vessel wall under flow is mediated by von Willebrand factor–binding protein

Jorien Claes, Thomas Vanassche, Marijke Peetermans, Laurens Liesenborghs, Christophe Vandenbriele, Karen Vanhoorelbeke, Dominique Missiakas, Olaf Schneewind, Marc F. Hoylaerts, Ruth Heying, Peter Verhamme

Blood (2014) 124 (10): 1669–1676.

https://doi.org/10.1182/blood-2014-02-558890

Published: 2014

Includes: Multimedia, Supplemental data

Journal Articles

PEAR1 attenuates megakaryopoiesis via control of the PI3K/PTEN pathway

Alexandre Kauskot, Christophe Vandenbriele, Sophie Louwette, Rik Gijsbers, Thomas Tousseyn, Kathleen Freson, Peter Verhamme, Marc F. Hoylaerts

Blood (2013) 121 (26): 5208–5217.

https://doi.org/10.1182/blood-2012-10-462887

Published: 2013

Includes: Supplemental data

Journal Articles

Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry

Blood (2012) 120 (21): 499.

https://doi.org/10.1182/blood.V120.21.499.499

Published: 2012

Journal Articles

A novel mechanism of sustained platelet αIIbβ3 activation via PEAR1

Alexandre Kauskot, Michela Di Michele, Serena Loyen, Kathleen Freson, Peter Verhamme, Marc F. Hoylaerts

Blood (2012) 119 (17): 4056–4065.

https://doi.org/10.1182/blood-2011-11-392787

Published: 2012

Includes: Supplemental data

Journal Articles

Phase I Clinical Trial of a Novel, Long-Acting Antithrombotic Drug: A Human Monoclonal Antibody Partially Inhibiting FVIII Activity.

Peter Verhamme, MD, PhD, Steve Pakola, MD, Marc Jacquemin, MD, PhD, Jean Marie Saint-Remy, MD, PhD, Jean Marie Stassen, PhD, Desire Collen, MD, PhD, Rikke Riisbro, MD, PhD, Thomas Jensen, MD, PhD, Steven Glazer, MD

Blood (2007) 110 (11): 312.

https://doi.org/10.1182/blood.V110.11.312.312

Published: 2007

NARROW

Long-Term Bleeding Protection, Sustained FIX Activity, Reduction of FIX Consumption and Safety of Hemophilia B Gene Therapy: Results from the HOPE-B Trial 3 Years after Administration of a Single Dose of Etranacogene Dezaparvovec in Adult Patients with Severe or Moderately Severe Hemophilia B

Effects of Andexanet Alfa on Thrombin Generation in Bleeding Associated with Factor Xa Inhibitors

Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study: A Perioperative Management Plan for Patients with Atrial Fibrillation Who Are Receiving a Direct Oral Anticoagulant

D-Dimer Levels and Risk of Recurrence Following Provoked Venous Thromboembolism: Findings from the Riete Registry

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Interm Report of the Highlow Study: A Randomized Controlled Trial Comparing Two Doses of Low Molecular Weight Heparin for the Prevention of Pregnancy-Associated Recurrent Venous Thromboembolism

Allele-specific DNA methylation reinforces PEAR1 enhancer activity

Antithrombotic Treatment and Outcomes of Splanchnic Vein Thrombosis in an International Prospective Registry: Results of 2-Year Follow-up

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

Adhesion of Staphylococcus aureus to the vessel wall under flow is mediated by von Willebrand factor–binding protein

PEAR1 attenuates megakaryopoiesis via control of the PI3K/PTEN pathway

Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry

A novel mechanism of sustained platelet αIIbβ3 activation via PEAR1

Phase I Clinical Trial of a Novel, Long-Acting Antithrombotic Drug: A Human Monoclonal Antibody Partially Inhibiting FVIII Activity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only